174 related articles for article (PubMed ID: 15967087)
1. Medullary thyroid carcinoma: management of lymph node metastases.
Quayle FJ; Moley JF
Curr Treat Options Oncol; 2005 Jul; 6(4):347-54. PubMed ID: 15967087
[TBL] [Abstract][Full Text] [Related]
2. Medullary thyroid carcinoma: management of lymph node metastases.
Moley JF
J Natl Compr Canc Netw; 2010 May; 8(5):549-56. PubMed ID: 20495084
[TBL] [Abstract][Full Text] [Related]
3. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
Jin LX; Moley JF
Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based approach to the management of sporadic medullary thyroid carcinoma.
Moley JF; Fialkowski EA
World J Surg; 2007 May; 31(5):946-56. PubMed ID: 17426901
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
[TBL] [Abstract][Full Text] [Related]
6. Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection.
Moley JF; DeBenedetti MK
Ann Surg; 1999 Jun; 229(6):880-7; discussion 887-8. PubMed ID: 10363903
[TBL] [Abstract][Full Text] [Related]
7. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
8. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
9. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
10. Can We Predict the Lateral Compartment Lymph Node Involvement in RET-Negative Patients with Medullary Thyroid Carcinoma?
Chandeze MM; Noullet S; Faron M; Trésallet C; Godiris-Petit G; Tissier F; Buffet C; Leenhardt L; Chereau N; Menegaux F
Ann Surg Oncol; 2016 Oct; 23(11):3653-3659. PubMed ID: 27271930
[TBL] [Abstract][Full Text] [Related]
11. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
Machens A; Lorenz K; Weber F; Dralle H
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951
[TBL] [Abstract][Full Text] [Related]
12. Surgical approach to the management of medullary thyroid cancer: when is lymph node dissection needed?
Stamatakos M; Paraskeva P; Katsaronis P; Tasiopoulou G; Kontzoglou K
Oncology; 2013; 84(6):350-5. PubMed ID: 23689063
[TBL] [Abstract][Full Text] [Related]
13. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
14. Radioactive iodine treatment in medullary thyroid carcinoma.
Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
[TBL] [Abstract][Full Text] [Related]
15. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
[TBL] [Abstract][Full Text] [Related]
16. Neck management in medullary thyroid carcinoma.
Oskam IM; Hoebers F; Balm AJ; van Coevorden F; Bais EM; Hart AM; van den Brekel MW
Eur J Surg Oncol; 2008 Jan; 34(1):71-6. PubMed ID: 17555910
[TBL] [Abstract][Full Text] [Related]
17. Medullary thyroid carcinoma.
Moley JF
Curr Treat Options Oncol; 2003 Aug; 4(4):339-47. PubMed ID: 12943614
[TBL] [Abstract][Full Text] [Related]
18. Repeat mediastinal lymph-node dissection for palliation in advanced medullary thyroid carcinoma.
Machens A; Gimm O; Ukkat J; Sutter T; Dralle H
Langenbecks Arch Surg; 1999 Jun; 384(3):271-6. PubMed ID: 10437616
[TBL] [Abstract][Full Text] [Related]
19. Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma.
Dralle H; Damm I; Scheumann GF; Kotzerke J; Kupsch E; Geerlings H; Pichlmayr R
Surg Today; 1994; 24(2):112-21. PubMed ID: 8054788
[TBL] [Abstract][Full Text] [Related]
20. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
